GLOBALMalwareHealthcareHealthcareRansomwareBianlianRansom DemandedActor NamedData Leak ThreatenedMedium
Piramal Group
bd_b1bbf13aa51e1ece · schema v1 · pii pii-v1
Full breach record for Piramal Group →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group BianLian on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Group activity: HealthcareDiscovered: 2023-06-28
Source: Ransomware.live
Post text · scraped from the leak site
Piramal Enterprises is a global business conglomerate with a diverse interest in Pharma, Financial Services, Healthcare Information Management, Real Estate and Glass Packaging.
Tracked as a single-filing incident — the only disclosure on record for this event so far.Unverified claimView incident
No regulatory filing corroborates this yet. If an SEC 8-K, state-AG notice, or victim statement lands, DisclosureLens will merge it into an incident and link it here.
Source provenance
- Source URL
- https://www.ransomware.live/id/UGlyYW1hbCBHcm91cEBiaWFubGlhbg==
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Jun 28, 2023
- Raw hash
- 479d8884da61ac4895556980f09d92c77f0e17f923105acc001447c17f7dddab
Reporting entity
- Name
- bianlian
Victim entity
- Name
- Piramal Groupnorm: piramal group
- Domain
- piramal.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· bianlian
- Threat actor
- BianlianExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.